adMare BioInnovations
Overview
adMare BioInnovations is a pan-Canadian not-for-profit life sciences venture builder and accelerator that invests pre-seed capital and provides R&D infrastructure and expertise to translate academic research into commercially viable therapeutics.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Abdera Therapeutics | Apr 2023 | Series A | Co-investor |
| TATUM Bioscience | May 2024 | Accelerator | Lead |
| Juno Technologies | May 2024 | Grant | Co-investor |
| Bright Angel Therapeutics | Dec 2019 | Seed | Co-investor |
| Thryv Therapeutics | Nov 2026 | Series B | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is adMare BioInnovations based?
adMare BioInnovations is headquartered in Vancouver, Canada.
When was adMare BioInnovations founded?
adMare BioInnovations was founded in 2019.
How many portfolio companies does adMare BioInnovations have?
adMare BioInnovations has 20 portfolio companies in Caplight's dataset.
What are some companies in adMare BioInnovations's portfolio?
Portfolio companies visible on Caplight include Abdera Therapeutics, TATUM Bioscience, Juno Technologies, Bright Angel Therapeutics, Thryv Therapeutics.
What was adMare BioInnovations's most recent investment shown here?
adMare BioInnovations's most recent investment in this portfolio sample was in Thryv Therapeutics in 2026.
What sectors does adMare BioInnovations focus on?
adMare BioInnovations focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech, Consumer & Commerce, Frontier & Industrial Tech.
What company stages does adMare BioInnovations focus on?
adMare BioInnovations typically invests at the Early stage.
What is adMare BioInnovations's AUM?
adMare BioInnovations's assets under management are estimated between $100.0M and $250.0M.